Skip to main content

Diagnosis, Prevention, and Treatment of Hypertensive Emergency/Hypertensive Crisis/Refractory Hypertension

  • Chapter
  • First Online:
Cardiology Consult Manual
  • 1275 Accesses

Abstract

Hypertension (HTN) is one of the major risk factors for cardiovascular disease (including stroke, coronary artery disease, heart failure, and atrial fibrillation). HTN affects almost one-third (29.1%) of all Americans, a number expected to climb as the population ages. These rapid and worrisome elevations in blood pressure account for many visits to emergency departments and urgent treatment in primary care settings. Patients with hypertensive crises may be asymptomatic or may present with encephalopathy, chest pain, heart failure, headache, epistaxis, and several other clinical disorders. The approach to treating these patients varies widely throughout the world, primarily because of the lack of quality clinical trial data that guides the treatment of this fairly large population of patients with hypertensive crises.

In this chapter, the categorization of hypertensive emergencies and urgencies will be reviewed. While most of the patients have longstanding primary HTN with sometimes erratic and inadequate treatment, the hypertensive crisis may also be an indicator of another underlying clinical process. The pathophysiology and epidemiology of these conditions will be discussed. Additionally, the use and indications for various parenteral and intravenous drugs will be described. Lastly, the evaluation and treatment of refractory HTN will also be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The presence of an upper-abdominal bruit with a diastolic component that lateralizes toward one side is highly suggestive of renal artery stenosis.

References

  1. Pak KJ, Hu T, Fee C, Wang R, Smith M, Bazzano LA. Acute hypertension: a systematic review and appraisal of guidelines. Ochsner J. 2014;14(4):655–63.

    PubMed  PubMed Central  Google Scholar 

  2. Boudville N, Ward S, Benaroia M, House AA. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens. 2005;18(10):1300–5.

    Article  CAS  PubMed  Google Scholar 

  3. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996;27(1):144–7.

    Article  CAS  PubMed  Google Scholar 

  4. Johnson W, Nguyen ML, Patel R. Hypertension crisis in the emergency department. Cardiol Clin. 2012;30(4):533–43.

    Article  PubMed  Google Scholar 

  5. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131(6):1949–62.

    Article  CAS  PubMed  Google Scholar 

  6. Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol. 1998;9(1):133–42.

    PubMed  CAS  Google Scholar 

  7. Bales A. Hypertensive crisis. How to tell if it’s an emergency or an urgency. Postgrad Med. 1999;105(5):119–26, 30

    Article  CAS  PubMed  Google Scholar 

  8. Braunwald E. Heart disease: a textbook of cardiovascular medicine. 6th ed. Philadelphia: W.B. Saunders; 2001.

    Google Scholar 

  9. Kaplan NM, Lieberman E, Neal W. Kaplan’s clinical hypertension. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2002.

    Google Scholar 

  10. Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001;14(11 Pt 1):1154–67.

    Article  CAS  PubMed  Google Scholar 

  11. O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23(4):697–701.

    Article  PubMed  Google Scholar 

  12. Betensky BP, Jaeger JR, Woo EY. Unequal blood pressures: a manifestation of subclavian steal. Am J Med. 2011;124(8):e1–2.

    Article  PubMed  Google Scholar 

  13. Mancia G, Fagard R, Narkiewicz K, Redán J, Zanchetti A, Böhm M, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925–38.

    Article  CAS  Google Scholar 

  14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.

    Article  CAS  PubMed  Google Scholar 

  15. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.

    Article  PubMed  Google Scholar 

  16. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.

    Article  PubMed  Google Scholar 

  17. Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature. J Gen Intern Med. 2002;17(12):937–45.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Laragh JH, Brenner BM. Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1995.

    Google Scholar 

  19. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259(2):225–8.

    Article  CAS  PubMed  Google Scholar 

  20. Houston M. Hypertensive emergencies and urgencies: pathophysiology and clinical aspects. Am Heart J. 1986;111(1):205–10.

    Article  CAS  PubMed  Google Scholar 

  21. Pollack CV, Rees CJ. Hypertensive emergencies: acute care evaluation and management. Emergency Medicine Cardiac Research Education Group. 2008;3:1–11.

    Google Scholar 

  22. Mishra SI, Jones-Burton C, Fink JC, Brown J, Bakris GL, Weir MR. Does dietary salt increase the risk for progression of kidney disease? Curr Hypertens Rep. 2005;7(5):385–91.

    Article  CAS  PubMed  Google Scholar 

  23. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54(3):475–81.

    Article  CAS  PubMed  Google Scholar 

  24. Zeller KR, Von Kuhnert L, Matthews C. Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. Arch Intern Med. 1989;149(10):2186–9.

    Article  CAS  PubMed  Google Scholar 

  25. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276(16):1328–31.

    Article  CAS  PubMed  Google Scholar 

  26. Bender SR, Fong MW, Heitz S, Bisognano JD. Characteristics and management of patients presenting to the emergency department with hypertensive urgency. J Clin Hypertens (Greenwich). 2006;8(1):12–8.

    Article  Google Scholar 

  27. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:510–26.

    Article  Google Scholar 

  28. Dudenbostel T, Siddiqui M, Oparil S, Calhoun DA. Refractory hypertension: a novel phenotype of antihypertensive treatment failure. Hypertension. 2016;67(6):1085–92.

    Article  CAS  PubMed  Google Scholar 

  29. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125(13):1635–42.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief. 2013;(133):1–8.

    Google Scholar 

  31. Egan BM, Zhao Y, Li J, Brzezinski WA, Todoran TM, Brook RD, et al. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network. Hypertension. 2013;62(4):691–7.

    Article  CAS  PubMed  Google Scholar 

  32. Muxfeldt ES, Nogueira Ada R, Salles GF, Bloch KV. Demographic and clinical characteristics of hypertensive patients in the internal medicine outpatient clinic of a university hospital in Rio de Janeiro. Sao Paulo Med J. 2004;122(3):87–93.

    Article  PubMed  Google Scholar 

  33. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57(6):1076–80.

    Article  CAS  PubMed  Google Scholar 

  34. Sim JJ, Bhandari SK, Shi J, Liu IL, Calhoun DA, McGlynn EA, et al. Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system. Mayo Clin Proc. 2013;88(10):1099–107.

    Article  PubMed  Google Scholar 

  35. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998;31(2):712–8.

    Article  CAS  PubMed  Google Scholar 

  36. Stergiou GS, Myers MG, Reid JL, Burnier M, Narkiewicz K, Viigimaa M, et al. Setting-up a blood pressure and vascular protection clinic: requirements of the European Society of Hypertension. J Hypertens. 2010;28(8):1780–1.

    Article  CAS  PubMed  Google Scholar 

  37. Faselis C, Doumas M, Papademetriou V. Common secondary causes of resistant hypertension and rational for treatment. Int J Hypertens. 2011;2011:236239.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71(19):e127–248.

    Google Scholar 

  39. Sica DA. Chlorthalidone: has it always been the best thiazide-type diuretic? Hypertension. 2006;47(3):321–2.

    Article  CAS  PubMed  Google Scholar 

  40. Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension. 2002;39(5):982–8.

    Article  CAS  PubMed  Google Scholar 

  41. Calhoun DA, White WB. Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension. J Am Soc Hypertens. 2008;2(6):462–8.

    Article  PubMed  Google Scholar 

  42. Chapman N, Dobson J, Wilson S, Dahlof B, Sever PS, Wedel H, et al. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension. 2007;49(4):839–45.

    Article  CAS  PubMed  Google Scholar 

  43. Nishizaka MK, Zaman MA, Calhoun DA. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens. 2003;16(11 Pt 1):925–30.

    Article  CAS  PubMed  Google Scholar 

  44. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.

    Article  CAS  PubMed  Google Scholar 

  45. Bobrie G, Frank M, Azizi M, Peyrard S, Boutouyrie P, Chatellier G, et al. Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study. J Hypertens. 2012;30(8):1656–64.

    Article  CAS  PubMed  Google Scholar 

  46. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011;58(7):765–73.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jesse Alan Doran .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Doran, J.A., Bisognano, J. (2018). Diagnosis, Prevention, and Treatment of Hypertensive Emergency/Hypertensive Crisis/Refractory Hypertension. In: Mieszczanska, H., Budzikowski, A. (eds) Cardiology Consult Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-89725-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-89725-7_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-89724-0

  • Online ISBN: 978-3-319-89725-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics